Key Information
Source
summary/abstract
Scott and Kelly share their journeys from diagnosis to treatment
For many people living with ATTR (transthyretin amyloidosis)—an underdiagnosed disease that involves the buildup of TTR amyloid in the body1—one thought that can linger after diagnosis is: I wish I had known sooner. Earlier answers can mean earlier treatment—and a jump-start toward slowing the progression of certain types and symptoms of ATTR.2,3 Scott and Kelly know this all too well. Both spent years trying to make sense of seemingly unrelated symptoms, before learning they were living with forms of this rare disease.
Now, they’re using their experiences to help others recognize symptoms and take action sooner.